Prolonged course of novel coronavirus infection COVID-19 with the formation of pulmonary fibrosis in an HIV-infected patient
https://doi.org/10.22625/2072-6732-2024-16-1-87-93
Abstract
A description of a clinical case of a severe, protracted course of coronavirus infection (COVID-19) in a patient with advanced stage HIV infection, characterized by prolonged release of the SARS-CoV-2 virus and the formation of pulmonary fibrosis against the background of an active viral infection, is presented. COVID-19 infection occurred in an immunosuppressed patient without ART. During the period of inpatient treatment, a comprehensive examination was carried out to exclude HIV-associated lung lesions; no evidence of viral, fungal, or bacterial pathology was obtained; mycobacterial infections were also excluded. Despite two courses of antiviral therapy, the use of anti-Covid plasma and complex pathogenetic therapy, persistence of SARS-CoV-2 replication was observed for eight months, with a steady progression of the disease, ending in death.
About the Authors
M. A. Savchenko
Clinical Infectious Disease Hospital named after S.P. Botkin
Russian Federation
Russian Federation
Saint-Petersburg
V. B. Musatov
Clinical Infectious Disease Hospital named after S.P. Botkin;
Saint-Petersburg State University
Russian Federation
Russian Federation
Saint-Petersburg
D. A. Gusev
Clinical Infectious Disease Hospital named after S.P. Botkin;
National Medical Research Centre named after V.A. Almazov
Russian Federation
Russian Federation
Saint-Petersburg
V. A. Cinzerling
Clinical Infectious Disease Hospital named after S.P. Botkin;
National Medical Research Centre named after V.A. Almazov
Russian Federation
Russian Federation
Saint-Petersburg
References
1. Varshney K. et al. Risk Factors for COVID-19 Mortality Among People Living with HIV: A Scoping Review // AIDS behav. 2022. Vol. 26, №7. P. 2256-2265.
2. Hu S. et al. Altered Expression of ACE2 and Co-receptors of SARS-CoV-2 in the Gut Mucosa of the SIV Model of HIV/ AIDS // Front microbiol. 2022. Vol. 13.
3. Nomah D. K. et al. HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups // Curr HIV/AIDS Rep. 2022. Vol. 19, № 1. P. 17-25.
4. Lee K. W. et al. COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis // Int J Environ Res Public Health. 2021. Vol. 18, № 7. P. 3554.
5. SeyedAlinaghi S. et al. COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review // Eur J Med Res. 2022. Vol. 27, № 1. P. 195.
6. Spinelli M.A. et al. COVID-19 Outcomes and Risk Factors Among People Living with HIV // Curr HIV/AIDS Rep. 2022. Vol. 19, №5. P. 425-432.
7. Mazzitelli M. et al. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral
8. Treatment and with Undetectable HIV RNA // Viruses. 2022. Vol. 14, № 3. P. 493.
9. Pobegalova O.E., Lioznov D.A., Antonova T.V., Shuklina M.A., Shurygina A.-P. T-cell immune response to SARS-CoV-2 in HIV patients // Infekc. bolezni (Infectious Diseases). 2023. Vol. 21, №1. P. 5–9. (In Russian).
10. Perumal R. et al. Long COVID: a review and proposed visualization of the complexity of long COVID // Front Immunol. 2023. Vol.14.
11. Peluso MJ, Antar AAR. Long COVID in people living with HIV // Curr Opin HIV AIDS. 2023. Vol. 18, №3. P.126-134.
12. Augello M. et al. Immunologic Interplay Between HIV/ AIDS and COVID-19: Adding Fuel to the Flames? // Curr HIV/ AIDS Rep. 2023. Vol. 20, № 2. P.51-75.
13. Duong-Quy S. et al. Post-COVID-19 Pulmonary Fibrosis: Facts-Challenges and Futures: A Narrative Review // Pulm Ther. 2023. Vol. 9, № 3. P. 295-307
14. Ankit Bharat et al. Lung transplantation for patients with severe COVID-19 // Sci. Transl. 2020. Vol. 12.
15. Cribbs S.K. et al. Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation // Physiol Rev. 2020. Vol. 100, № 2. P. 603-632.
16. Ilieva K., Karnaukhova E.Yu., Pobegalova O.E., Lioznov D.A. Clinical cases of pneumocystis pneumonia in patients with HIV infection and underlying COVID-19 // Journal Infectology. 2022. Vol. 14, № 4. P.126-131.
17. Razafindrasoa Z.A., Razafimpihanina SM, Rasoafaranirina MO, et al. Diagnostic challenge of dyspnea in the context of the COVID-19 pandemic wave: a case report // Egypt J Intern Med. 2023. Vol. 35, № 1. Р. 9.
18. Alrubayyi A. et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV // Nat Commun. 2021. Vol. 12.
19. Lee J. et al. Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study // Cancers (Basel). 2021. Vol. 13, № 3. P. 471.
20. Mir M. et al. The Role of Computed Tomography in the Management of Hospitalized Patients With COVID-19 // Cureus. 2023. Vol.15, № 3.
21. Karim F. et al. Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection // medRxiv. 2021.
22. Zinserling V.A. et al. SARS-CoV-2-Induced PathologyRelevance to COVID-19 Pathophysiology // Pathophysiology. 2022. Vol.29, № 2, P. 281-297.
23. Jyothula S.S.K. et al. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation // EBioMedicine. 2022. Vol. 86.
24. Metodicheskie rekomendacii «Osobennosti techenija Long-COVID-infekcii. Terapevticheskie i reabilitacionnye meroprijatija» // Terapija. 2022. Prilozhenie 1. – P. 1–147.
25. Peluso M.J. et al. Early clues regarding the pathogenesis of long COVID // Trends Immunol. 2022. Vol. 43, № 4. P.268-270.
26. Zinserling V.A. Infectious Pathology of the Respiratory Tract. 2021. Springer International Publishing. P. 67-78.
Review
For citations:
Savchenko M.A., Musatov V.B., Gusev D.A., Cinzerling V.A. Prolonged course of novel coronavirus infection COVID-19 with the formation of pulmonary fibrosis in an HIV-infected patient. Journal Infectology. 2024;16(1):87-93. (In Russ.) https://doi.org/10.22625/2072-6732-2024-16-1-87-93
Views:
299
.png)
.png)
Email this article 